高级搜索

益生菌在肿瘤治疗中的应用:作用机制、临床争议与个体化前景

The Use of Probiotics in Cancer Treatment: How They Work, Clinical Debates, and Personalized Prospects

  • 摘要: 肠道微生物群在肿瘤发生、发展及治疗响应中的关键作用已被广泛证实。益生菌作为调节微生态平衡的重要工具,在肿瘤辅助治疗领域展现出巨大潜力,但其临床转化仍面临显著争议与挑战。本综述首先系统梳理了益生菌在肿瘤治疗中的应用现状,重点阐述其通过免疫检查点通路调控、代谢产物(尤其是短链脂肪酸)介导的抗增殖效应、肠道屏障强化及肿瘤微环境免疫重塑等多条途径发挥辅助抗肿瘤作用的分子机制。在此基础上,文章客观分析了益生菌在增强化疗与免疫检查点抑制剂(ICIs)疗效、减轻治疗相关毒性方面的临床证据,并特别强调了益生菌在ICIs治疗中存在的矛盾证据与潜在风险。最后,本文深入讨论了当前临床转化面临的菌株特异性、安全性及证据异质性等核心挑战,并展望了基于多组学整合与基因工程改造的下一代个体化益生菌疗法的发展方向,以期为微生物组精准辅助治疗策略的制定提供参考。

     

    Abstract: The critical role of gut microbiota in tumorigenesis, progression and treatment response has been widely confirmed. As an important tool for regulating microecological balance, probiotics have shown great potential in the field of adjuvant tumor therapy, but their clinical translation still faces significant controversies and challenges. This review first systematically sorts out the current application status of probiotics in tumor therapy, and focuses on elaborating the molecular mechanisms by which probiotics exert adjuvant anti-tumor effects through multiple pathways, including immune checkpoint pathway regulation, anti-proliferative effects mediated by metabolites (especially short-chain fatty acids), intestinal barrier strengthening, and immune remodeling of the tumor microenvironment. On this basis, the article objectively analyzes the clinical evidence of probiotics in enhancing the efficacy of chemotherapy and immune checkpoint inhibitors (ICIs) and reducing treatment-related toxicity, and particularly emphasizes the conflicting evidence and potential risks of probiotics in ICIs therapy. Finally, this review deeply discusses the core challenges faced by current clinical translation, such as strain specificity, safety and evidence heterogeneity, and looks forward to the development direction of next-generation personalized probiotic therapies based on multi-omics integration and genetic engineering modification, in order to provide a reference for the formulation of precise microbiome-based adjuvant treatment strategies.

     

/

返回文章
返回